NCT04110808

Brief Summary

AIM OF THE WORK The aim of this work was to compare the effect of hypotensive anaesthesia using Nitroglycerine versus phentolamine on Event related potentials, quantitative Electroencephalograghy and cognitive function, in patients undergoing septoplasty.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Oct 2019

Shorter than P25 for early_phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2019

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
14 days until next milestone

Study Start

First participant enrolled

October 15, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

October 1, 2019

Status Verified

September 1, 2019

Enrollment Period

3 months

First QC Date

September 6, 2019

Last Update Submit

September 28, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Paired Associate Learning test for assessment of Cognitive function

    Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine

    1 week

  • Benton Visual Retention test for assessment of Cognitive function

    Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine

    1 week

Secondary Outcomes (2)

  • Quantitative Electroencephalograghy for assessment of electrical activity of the brain

    1 week

  • Event related potentials (ERP ) P300 for neurophysiological assessment of cognition

    1 week

Study Arms (2)

Nitroglycerine

ACTIVE COMPARATOR

Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final concentration of 100μg/ml at the rate of 0.5- 10 μg/kg/min according to the patients desired target blood pressure.

Drug: hypotensive anaesthesia using Nitroglycerine

Phentolamine

OTHER

Patients will receive hypotensive anesthesia with phentolamine infusion via syringe pump by adding 20 mg (2ml) of Phentolamine to 48 ml of normal saline making it to final concentration of 0.4 mg/ml at the rate of 0.1-2 mg/min according to the patients desired target blood pressure.

Drug: hypotensive anaesthesia using Nitroglycerine

Interventions

effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine on Event related potentials, quantitative Electroencephalograghy and cognitive function Phentolamine group (30 patients): Patients will receive hypotensive anesthesia with phentolamine infusion via syringe pump by adding 20 mg (2ml) of Phentolamine to 48 ml of normal saline making it to final concentration of 0.4 mg/ml at the rate of 0.1-2 mg/min according to the patients desired target blood pressure. Nitroglycerine group (30 patients): Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final concentration of 100μg/ml at the rate of 0.5- 10 μg/kg/min according to the patients desired target blood pressure.

Also known as: hypotensive anaesthesia using Phentolamine
NitroglycerinePhentolamine

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who are candidate for septoplasty
  • Patients from both sexes, aged between 20-50 years

You may not qualify if:

  • Patients who develop intraoperative shock or major bleeding
  • Patients with ischemic heart diseases, heart block, congestive heart failure, valvular heart diseases, or uncontrolled hypertension
  • Patients with a history of central neurological system disorder
  • Patients with concomitant medical or metabolic illness known to affect cognition
  • Pregnant females
  • Allergy to any of the anaesthetic or hypotensive drugs used in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neurology lecturer

Study Record Dates

First Submitted

September 6, 2019

First Posted

October 1, 2019

Study Start

October 15, 2019

Primary Completion

January 1, 2020

Study Completion

February 1, 2020

Last Updated

October 1, 2019

Record last verified: 2019-09